# CAN SLIM Progress Board

Last updated: 2026-09-14

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The theory-fidelity path now has frozen contracts through #47, with #48 major-index source audit complete. #43 remains the current stock-level lifecycle arbiter; #44 is climax/exhaustion evidence-only; #45/#46 form the portfolio-level CAN SLIM `M` state-to-exposure path; #47/#48 now define and validate its major-index input boundary.

## Repository boundary for #33

**Canonical #33 implementation and P8 morphology validation live in `azharmz/ussy-oneil-patterns`.** Frozen production contract: `oneil-pattern-output-v2` with only `FLAT_BASE`, `DOUBLE_BOTTOM`, `CUP_WITHOUT_HANDLE`, and `CUP_WITH_HANDLE`. P6 advanced patterns remain excluded and frozen.

## Theory Fidelity / v2 path

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | Theory-faithful candidate specification | **COMPLETE / FROZEN v1** |
| 33 | O'Neil Pattern Recognition Engine | **CORE COMPLETE / FROZEN — P8 CONDITIONAL PASS** |
| 34 | Theory-faithful candidate generator | **COMPLETE / FROZEN v1** |
| 35 | New-candidate validation | **COMPLETE / FROZEN — CONDITIONAL PASS** |
| 36 | Execution / entry research | **BASELINE FROZEN / DIAGNOSTIC COMPLETE / PRIMARY PERFORMANCE VALIDATION BLOCKED_ON_ELIGIBLE_POPULATION** |
| 37 | Sell / risk execution semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 38 | Technical deterioration evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 39 | Weekly aggregation / 10-week evidence | **WEEKLY AGGREGATION + 10W EVIDENCE COMPLETE / FROZEN v1** |
| 40 | Technical deterioration action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 41 | Position lifecycle / exit arbiter | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 42 | Round-trip sell action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 43 | Position lifecycle / exit arbiter v2 | **IMPLEMENTATION COMPLETE / FROZEN v2** |
| 44 | Climax / exhaustion evidence | **EVIDENCE LAYER COMPLETE / FROZEN v1** |
| 45 | Market exposure action semantics | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 46 | Market state evidence / classification | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 47 | Market input data contract | **IMPLEMENTATION COMPLETE / FROZEN v1** |
| 48 | Major index source audit | **SOURCE AUDIT COMPLETE — YAHOO/YFINANCE APPROVED FOR INITIAL PRODUCTION INPUT v1** |

## Current canonical architecture

```text
STOCK
#33 Pattern → #34 Candidate → #35 Validation → #36 Entry
→ OPEN POSITION
→ #37 Capital Protection / #40 Technical Deterioration / #42 Round-Trip
→ #43 Stock Lifecycle Arbiter → CLOSED POSITION

#44 Climax/Exhaustion = evidence sidecar only

GENERAL MARKET / CAN SLIM M
#47 canonical indexes + #48 audited source
NASDAQ_COMPOSITE(^IXIC) / SP500(^GSPC) / DJIA(^DJI)
→ #46 Market State Classification
→ #45 Portfolio Exposure Action
→ target exposure band E0..E4
```

## #34–#35 candidate and validation state

Frozen candidate stages: `BASE_RECOGNIZED → PIVOT_DEFINED → PIVOT_CROSSED → BREAKOUT_CONFIRMED → CANSLIM_ELIGIBLE`.

#34 final verification `34758050282` → **SUCCESS, 9 tests**. #35 canonical historical run `34763920536` produced 265,642 observations with zero V35-A/B/C findings and a frozen 60-case corpus. Independent source-evidence audit `34765922653` → **SUCCESS**, C/A/L/M 60/60 MATCH and PIT violations = 0. #35 remains `CONDITIONAL PASS` solely with upstream #33 morphology debt preserved.

## #36–#43 stock lifecycle

#36 canonical T+1-open execution remains frozen; primary performance validation remains `BLOCKED_ON_ELIGIBLE_POPULATION` because canonical #35 has 0 `CANSLIM_ELIGIBLE` observations.

#37 capital protection, #40 technical deterioration and #42 round-trip are the three frozen executable stock-level exit channels. #43 v2 arbitrates them by earliest causal executable exit, preserving same-session ambiguity/source conflicts rather than inventing an OHLC path.

Canonical validations remain green: #36 `34785545504`; #37 `34787905360`; #38 `34788119495`; #39 `34788414986`; #40 `34789559782`; #41 `34790106465`; #42 `34793348883`; #43 `34796938374`.

## #44 — Climax / Exhaustion Evidence

Contract `44-climax-exhaustion-evidence-v1` remains evidence-only. It records reproducible climax/exhaustion channels without creating a fourth exit. Prior-advance/base-stage context remains unresolved for a canonical action rule. EXH2 remains separate and unchanged. Canonical run `34797449482` → **SUCCESS, 10 passed**.

## #45 — Market Exposure Action

Contract `45-market-exposure-action-v1` remains frozen. Portfolio exposure vocabulary is E0=0-20%, E1=20-40%, E2=40-60%, E3=60-80%, E4=80-100%. Correction maps to E0/block new entries; follow-through permits gradual re-entry; healthy uptrend can raise at most one band; weakening lowers one band. It is portfolio-level and not a stock liquidation rule.

Canonical run `34802432732` / job `103847631050` → **SUCCESS, 12 passed**.

## #46 — Market State Evidence / Classification

Contract `46-market-state-classification-v1` remains frozen. State chronology is `CORRECTION → RALLY_ATTEMPT → FOLLOW_THROUGH_CONFIRMED → UPTREND_HEALTHY → UPTREND_WEAKENING`, with Day-1-low reset, Day-4+ follow-through, >=1.25% close gain and higher volume. Distribution evidence is >=0.20% decline on higher volume, but no universal distribution-count threshold is invented.

Canonical run `34803676270` / job `103851194650` → **SUCCESS, 13 passed**.

## #47 — Market Input Data Contract

Contract `47-market-input-data-contract-v1` freezes canonical major-index identities:

- `NASDAQ_COMPOSITE`
- `SP500`
- `DJIA`

SPY/QQQ/DIA are explicitly forbidden as canonical substitutes. Missing index volume is never imputed. Index identity, provider, source symbol, fetch timestamp and source-contract version are required provenance.

Semantic-validation run `34806193999` / job `103858438691` → **SUCCESS, 13 passed in 0.04s**.

## #48 — Major Index Source Audit

Audit executed in `azharmz/ussy-data` using preregistered diagnostics-only workflow.

Frozen provider mappings approved for initial production input v1:

```text
NASDAQ_COMPOSITE -> Yahoo/yfinance ^IXIC
SP500            -> Yahoo/yfinance ^GSPC
DJIA             -> Yahoo/yfinance ^DJI
```

Run `34807791390` / job `103862942417` completed successfully. Artifact `major-index-source-audit-34807791390` (id `10333836848`, digest `sha256:c4943ec895549b1ddd192f7a4c7d37704555fd6616db5cec6d436c19acfd5dab`) recorded 548 rows for each index from 2024-07-08 through 2026-09-11. All three passed non-empty/schema/date/OHLC/recent-volume completeness/nonnegative/nonzero/variation checks over the latest 60 returned sessions.

Decision: `docs/decisions/2026-09-14-48-major-index-source-audit-decision.md`.

Status: **SOURCE AUDIT COMPLETE / YAHOO-YFINANCE APPROVED FOR INITIAL PRODUCTION INPUT v1**.

## Forward / production boundaries

FWD1 remains LIVE / ACCUMULATING with its existing gate; EXH2 remains separate and prospective. Production integration remains blocked by the FWD1 gate. Theory-fidelity findings must not be retrofitted into FWD1/X3/EXH2.

## Active work from here

1. Keep #33-#47 frozen; preserve #48 audit decision unless new source-quality evidence requires reopening the provider layer only.
2. Primary lifecycle/performance validation remains blocked until a genuine frozen `CANSLIM_ELIGIBLE` population exists.
3. Do not tune entry, exits, lifecycle arbitration, climax evidence, market-state classification, source selection or exposure transitions from historical returns.
4. Next clean workstream is **production publication/wiring of the three #48-approved index series in `ussy-data`**, using immutable run objects + official pointers and the frozen #47 provenance/validation contract.
5. PIT `leadership_confirming` and `weakening_confirmed` still require separately versioned upstream evidence contracts before fully automatic `UPTREND_HEALTHY` / `UPTREND_WEAKENING` production state is complete.
6. A future portfolio executor may translate #45 target exposure into concrete position-level actions; that must not be conflated with stock-level O'Neil sell rules.
7. A canonical climax action remains unauthorized until prior-advance/base-stage context is resolved.
8. Preserve #33 morphology debt, keep P6 out of production, and keep FWD1/EXH2 unchanged.
